Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,618,141

Try a free trial See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,618,141 protect, and when does it expire?

Patent 8,618,141 protects NEXAVAR and is included in one NDA.

This patent has fifteen patent family members in eleven countries.

Summary for Patent: 8,618,141

Title:	Aryl ureas with angiogenesis inhibiting activity
Abstract:	This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
Inventor(s):	Dumas; Jacques (Bethany, CT), Scott; William J. (Guilford, CT), Elting; James (Madison, CT), Hatoum-Makdad; Holia (Hamden, CT)
Assignee:	Bayer Healthcare LLC (Whippany, NJ)
Application Number:	13/551,884
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,618,141
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 8,618,141
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 8,618,141

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bayer Hlthcare	NEXAVAR	sorafenib tosylate	TABLET;ORAL	021923-001	Dec 20, 2005		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				TREATMENT OF ADVANCED RENAL CELL CARCINOMA	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 8,618,141

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2003209116	➤ Sign Up
Canada	2475703	➤ Sign Up
Cyprus	1114314	➤ Sign Up
Denmark	1478358	➤ Sign Up
European Patent Office	1478358	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.